Caterina Scuderi

Pubblicazioni

Titolo Pubblicato in Anno
Astrocyte-neuron interplay in Alzheimer's disease: evidence from an innovative and promising pharmacological manipulation in a triple transgenic model of the disease 18 th World Congress of Basic and Clinical Pharmacology (WCP2018) 2018
Investigating the role of oligodendrocytes in a pharmacological model of autism spectrum disorders FENS Forum of Neuroscience 2018
The protective effects of ultramicronized palmitoylethanolamide on the glutamatergic system in a triple transgene mouse model of Alzheimer disease. 25th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) 2018
Reactive astrogliosis and neuronal impairment: in vitro and in vivo evidence on palmitoylethanolamide effects in a triple transgenic model of Alzheimer’s disease SINS Italian Society for Neuroscience 2018
Glia and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression Convegno Monotematico della Società Italiana di Farmacologia “Glial cells and therapeutic perspectives: from maladaptive plasticity to neurorestoration” 2018
Ultramicronized palmitoylethanolamide improves learning and memory in a triple transgenic mouse model of Alzheimer's disease through a combination of anti-inflammatory and neuroprotective effects 38th Spanish Society of Pharmacology meeting/9th Spanish Society of Pharmacogenetics and Pharmacogenomics meeting. 2018
Quale futuro per la terapia dell'Alzheimer? Evidenze dalla ricerca preclinica. ALZHEIMER, LA DIGNITÀ OLTRE LA CURA 2018
Quale futuro per la terapia delle malattie neurodegenerative:nuove evidenze dalla ricerca preclinica. Congresso della Società Italiana di Medicina di Genere nelle Neuroscienze “Donne in Neuroscienze, Neuromodulazione e Neuroplasticità’: principi e potenziale” 2018
Editorial: Neuroglia Molecular Mechanisms in Psychiatric Disorders FRONTIERS IN MOLECULAR NEUROSCIENCE 2018
Neuroglia in the autistic brain: evidence from a preclinical model MOLECULAR AUTISM 2018
Astrocyte: an innovative approach for Alzheimer's disease therapy CURRENT PHARMACEUTICAL DESIGN 2017
Effect of ultramicronized-palmytoilethanolamide on astrocyte dysfunction in a triple transgenic model of Alzheimer’s disease SIF Società Italiana Farmacologia 2017
Hippocampal metabolic and behavioural improvements after palmitoylethanolamide treatment at early stage of development in a triple transgene mouse model of Alzheimer disease. 8° Congresso della sezione italiana della International Society for Magnetic Resonance in Medicine (ISMRM) 2017
How could retinoids fit into Alzheimer's therapy? DRUGS OF THE FUTURE 2016
Targeting neuroinflammation in Alzheimer’s disease JOURNAL OF INFLAMMATION RESEARCH 2016
Effect of palmitoylethanolamide on astrocyte activity in a triple transgenic model of Alzheimer’s disease 10th FENS Forum of Neuroscience 2016
Effect of palmitoylethanolamide in a triple transgenic model of Alzheimer’s disease Monitoring Molecules in Neuroscience 2016
Metabolic and morphological characterization of the triple transgene mouse model of Alzheimer disease: effects of palmitoylethanolamide on the onset and progression of the AD-pathology 24th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) 2016
Effects of palmitoylethanolamide on the onset and progression of the pathology on a triple transgene mouse model of Alzheimer disease. 7° Congresso della sezione italiana della International Society for Magnetic Resonance in Medicine (ISMRM) 2016
Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of β amyloid-induced astrogliosis in vitro. CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma